Skip to main content

Table 2 Anti-HCV prevalence by demographic and exposure subgroup in unadjusted and adjusted models, Georgia HCV serosurvey, 2015

From: Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination

Characteristic

 

Anti-HCV Prevalence

Unadjusted Models

Final Adjusted Model

Total n

n

Weighted % (95% CI)

Crude OR (95% CI)

p-value

Adjusted OR (95% CI)

p-value

Demographics

       

 Sex

  Female

3671

145

3.8 (3.0, 4.9)

1

   

  Male

2339

288

12.1 (10.2, 14.3)

3.5 (2.5, 4.8)

< 0.0001

  

  Missing

0

      

 Age

  18–29

1063

23

2.4 (1.5, 4.0)

1

   

  30–39

1140

94

8.8 (6.8, 11.3)

3.9 (2.2, 6.8)

< 0.0001

  

  40–49

1026

128

14.0 (11.1, 17.6)

6.5 (3.9, 11.1)

< 0.0001

  

  50–59

1096

79

7.0 (5.2, 9.5)

3.0 (1.6, 5.8)

0.0006

  

  60+

1681

109

6.7 (5.0, 9.0)

2.9 (1.6, 5.4)

0.0007

  

  Missing

4

      

 Geography

  Urban

3155

290

9.5 (8.0, 11.4)

1.8 (1.4, 2.5)

< 0.0001

  

  Rural

2855

143

5.4 (4.4, 6.6)

1

   

  Missing

0

      

 Employment Status

  Employed/student/

4939

286

5.9 (5.0, 7.1)

1

   

  homemaker/unpaid

  worker/retired

   

  Unemployed*

1065

147

15.0 (12.3, 18.1)

2.8 (2.1, 3.7)

< 0.0001

  

  Missing

6

      

Exposures

       

 Ever injected drugs

  Yes

205

150

66.5 (56.0, 75.6)

37.6 (23.5, 60.0)

< 0.0001

21.4 (12.3, 37.4)

< 0.0001

  No

5762

283

5.0 (4.3, 5.9)

1

   

  Missing

43

      

 Ever incarcerated

  Yes

236

98

42.0 (32.8, 51.7)

11.3 (7.5, 17.1)

< 0.0001

  

  No

5757

335

6.0 (5.1, 7.0)

1

   

  Missing

17

      

 Have any tattoos

  Yes

626

104

16.2 (12.2, 21.1)

2.8 (1.9, 4.0)

< 0.0001

  

  No

5372

329

6.5 (5.5, 7.6)

1

   

  Missing

12

      

 Number of medical injections in last 6 months

  0

3656

233

6.7 (5.6, 7.9)

1

   

  1

541

40

6.6 (4.3, 10.2)

0.99 (0.60, 1.65)

0.98

  

  > 1

1648

144

9.5 (7.5, 12.1)

1.48 (1.10, 1.99)

0.01

  

 Missing

165

      

 Ever received a blood transfusion

  Yes

447

69

21.4 (15.6, 28.5)

3.8 (2.6, 5.5)

< 0.0001

4.5 (2.8, 7.2)

< 0.0001

  No

5554

364

6.7 (5.8, 7.7)

1

   

  Missing

9

      

 Received a blood transfusion before or after 1997

  Before 1997

225

36

25.3 (16.2, 37.3)

1.6 (0.7, 3.7)

0.27

  

  In or after 1997

222

33

17.4 (10.7, 27.1)

1

   

 Ever received kidney dialysis

  Yes

17

3

27.6 (7.9, 62.9)

4.6 (1.0, 20.4)

0.04

  

  No

5972

430

7.7 (6.7, 8.8)

1

   

  Missing

21

      

 Frequency of dental cleanings

  Twice/year

193

15

15.0 (8.1, 26.2)

2.1 (1.1, 4.4)

0.04

  

  Once/year

478

27

6.7 (3.9, 11.5)

0.9 (0.5, 1.6)

0.66

  

  Less than once/year

1108

84

6.9 (5.0, 9.4)

0.9 (0.6, 1.3)

0.58

  

  Never

4173

304

7.6 (6.5, 8.8)

1

   

  Missing

58

      

 Number of lifetime sexual partners

  0–2

4020

157

3.8 (3.0, 4.7)

1

   

  > 2

991

129

11.9 (9.1, 15.4)

3.4 (2.4, 5.0)

< 0.0001

  

  Missing

999

      
  1. Note: Anti-HCV related analyses include only participants who submitted both questionnaire data and a usable blood specimen (n = 6010)
  2. *Unemployed includes those able or unable to work